Case Letter

Treatment of Infantile Hemangiomas in Concomitant Tuberous Sclerosis Complex Should Prompt Evaluation for Cardiac Rhabdomyomas Prior to Initiation of Propranolol

Author and Disclosure Information

Practice Points

  • Dermatologists may see patients with infantile hemangiomas (IHs) and tuberous sclerosis complex (TSC); therefore, they should be familiar with TSC diagnostic criteria to reach a prompt diagnosis and make appropriate referrals.
  • Cardiologic evaluation is not routinely required prior to systemic treatment of IH, but knowledge of cardiac findings in TSC should prompt cardiologic clearance prior to β-blocker initiation.


 

References

To the Editor:

Cardiac rhabdomyomas are benign hamartomas that are common in patients with tuberous sclerosis complex (TSC). 1 We describe a patient who presented with large infantile hemangiomas (IHs) and hypopigmented macules, which prompted further testing that eventually showed concomitant multiple cardiac rhabdomyomas in the context of TSC.

A 5-week-old girl—who was born at 38 weeks and 3 days’ gestation via uncomplicated vaginal delivery—was referred to our pediatric dermatology clinic for evaluation of multiple erythematous lesions on the scalp and left buttock that were first noticed 2 weeks prior to presentation. There was a family history of seizures in the patient’s mother. The patient’s older brother did not have similar symptoms.

Physical examination revealed 2 nonulcerating erythematous nodules on the middle and posterior left vertex scalp that measured 2.5×2 cm (Figure 1A) as well as 1 bright red plaque on the left buttock (Figure 1B). Five hypopigmented macules, ranging from 5 mm to 1.5 cm in diameter, also were detected on the left thorax (Figure 2A) as well as the middle and lower back (Figure 2B). These findings, along with the history of seizures in the patient’s mother, prompted further evaluation of the family history, which uncovered TSC in the patient’s mother, maternal aunt, and maternal grandmother.

The large IHs on the scalp did not pose concerns for potential functional impairment but were still considered high risk for permanent alopecia based on clinical practice guidelines for the management of IH. 2 Treatment with oral propranolol was recommended; however, because of a strong suspicion of TSC due to the presence of 5 hypopigmented macules measuring more than 5 mm in diameter (≥3 hypopigmented macules of ≥5 mm is one of the major criterion for TSC), the patient was referred to cardiology prior to initiation of propranolol.

Echocardiography revealed 3 intracardiac masses measuring 4 to 5 mm in diameter in the left ventricle (LV), along the interventricular septum and the LV posterior wall. These masses were consistent with rhabdomyomas (Figure 3)—a major criterion for TSC—which had not been detected by prenatal ultrasonography. No obstruction to LV inflow or outflow was observed. Additionally, no arrhythmias were detected on electrocardiography.

The patient was cleared for propranolol, which was slowly uptitrated to 2 mg/kg/d. She completed the course without adverse effects. The treatment of IH was successful with substantial reduction in size over the following months until clearance. She also was referred to neurology for magnetic resonance imaging of the brain, which showed a 3-mm subependymal nodule in the lateral right ventricle, another major feature of TSC.

FIGURE 1 . Infantile hemangiomas. A, Two 2.5×2-cm erythematous nodules on the middle and posterior left vertex scalp. B, A bright red plaque on the left buttock.

Cardiac rhabdomyomas are benign hamartomas that affect as many as 80% of patients with TSC 1 and are primarily localized in the ventricles. Although cardiac rhabdomyomas usually regress over time, they can compromise ventricular function or valvular function, or both, and result in outflow obstruction, arrhythmias, and Wolff- Parkinson-White syndrome. 3 Surgical resection may be needed in patients whose condition is refractory to medical management for heart failure.

Pages

Recommended Reading

Celiac Disease: Five Things to Know
MDedge Dermatology
Are Children Born Through ART at Higher Risk for Cancer?
MDedge Dermatology
Latest Breakthroughs in Molluscum Contagiosum Therapy
MDedge Dermatology
A 7-year-old female presents with persistent pimples on the nose and cheeks for approximately 1 year
MDedge Dermatology
One Patient Changed This Oncologist’s View of Hope. Here’s How.
MDedge Dermatology
Pediatric Atopic Dermatitis: Study Suggests Treatment May Impact Atopic March
MDedge Dermatology
Topical Ruxolitinib Effective for AD in Study of Children Ages 2-11 years
MDedge Dermatology
Atopic Dermatitis: Study Compares Prevalence by Gender, Age, and Ethnic Background
MDedge Dermatology
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis
MDedge Dermatology
FDA Approves Topical Anticholinergic for Axillary Hyperhidrosis
MDedge Dermatology